top of page

Zyceva 150 mg Tablet

SKU Cadila Healthcare Ltd
Original price

$41.48

Sale price

$27.72

Zyceva 150 mg Tablet is a targeted anticancer therapy designed to combat specific types of malignancies, including non-small cell lung cancer (NSCLC) and pancreatic cancer. The active ingredient, erlotinib, works by inhibiting the epidermal growth factor receptor (EGFR), which plays a crucial role in the growth and spread of cancer cells. By blocking this receptor, Zyceva can effectively slow down or halt tumor progression, providing patients with a vital option in their cancer treatment journey. It's essential to note that Zyceva may lead to side effects such as skin rash, diarrhea, and fatigue, so close monitoring by healthcare professionals is recommended. Patients are advised to discuss any pre-existing conditions or medications with their doctor before starting this treatment to avoid potential interactions. As with any anticancer medication, adherence to the prescribed regimen is crucial for achieving the best possible outcomes. Zyceva represents a significant advancement in personalized cancer therapy, offering hope for those affected by these challenging diseases. Always consult a healthcare provider for comprehensive guidance tailored to individual health needs when considering Zyceva.

Quantity

Active Pharmaceutical Ingredient

Erlotinib 150 mg

Uses

• Zyceva 150 mg tablet is primarily indicated for the treatment of non-small cell lung cancer, a prevalent form of lung cancer that involves a significant number of lung cells. Patients may experience symptoms such as persistent cough, chest discomfort, and shortness of breath. The medication helps inhibit the growth of cancer cells, thereby potentially improving patient outcomes. By targeting specific pathways, Zyceva 150 mg tablet aids in managing this challenging condition.
• In cases of pancreatic cancer, Zyceva 150 mg tablet is often used in conjunction with gemcitabine to enhance treatment efficacy. Patients with pancreatic cancer may present with symptoms including abdominal pain, jaundice, and significant weight loss. The combination therapy aims to improve overall survival rates and alleviate some of the debilitating symptoms associated with this aggressive cancer. Zyceva 150 mg tablet plays a crucial role in this treatment regimen, helping to target cancerous cells more effectively.
• Zyceva 150 mg tablet is also utilized in personalized cancer treatment plans, where genetic profiling of tumors is conducted. This approach allows for more tailored therapy, enhancing the likelihood of a favorable response in patients with specific mutations. By incorporating Zyceva 150 mg tablet into these individualized plans, healthcare providers can improve treatment outcomes. The medication's targeted action can be particularly beneficial for patients with unique tumor characteristics.
• In clinical practice, Zyceva 150 mg tablet is frequently prescribed as part of a comprehensive management strategy for advanced cancer stages. It is often used when standard treatments have failed or when patients have specific biomarkers that suggest a higher likelihood of benefit. This strategic use of Zyceva 150 mg tablet aims to control disease progression and improve quality of life. By integrating this medication into treatment protocols, oncologists can provide patients with additional therapeutic options.

Benefits

Zyceva Tablet inhibits a protein called epidermal growth factor receptor (EGFR), which is involved in the growth and spread of cancer cells. By inhibiting this protein, Anti-cancer Drug Zyceva can help to slow the progression of cancer. Zyceva 150 mg Strip may be able to help reduce the severity of cancer-related symptoms, such as pain and fatigue, which may improve the patient's overall quality of life. Zyceva 150 mg may be used in combination with other cancer treatments, such as chemotherapy, to improve their effectiveness.

Side Effects

Like all medications, Zyceva 150 mg Strip can cause side effects but do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them.

Most Common Side Effects

• Diarrhea
• Vomiting
• Gas
• Heartburn
• Mouth sores
• Constipation
• Headache
• Weight Loss
• Muscle or bone pain
• Anxiety
• Depression
• Hair loss
• Swelling of hands, feet, arms, lower legs or ankles
• Changes in nail and hair appearance

Common Side Effects

• Sudden chest pain
• Severe stomach pain
• Vision problems
• Heart attack
• Stroke
• Kidney or liver problems
• Rash
• Cough
• Peeling, blistering, cracked or dry skin
• Itching
• Tenderness
• Burning of the skin
• Fever
• Ingrown eyelash
• Pain in the neck, upper back or arms
• Difficult or slow speech
• Dizziness
• Weakness
• Dry mouth
• Dark urine
• Yellow or pale skin

How To Use

Take this medicine on an empty stomach, one hour before food or two hours after food. It is best to take exactly as prescribed by your doctor. Do not take more or less than directed. If you have trouble swallowing the Zyceva 150 mg, you may crush the tablets and mix the powder with a small amount of water. Drink the mixture immediately. You should take the Zyceva 150 mg Tablet at the same time each day to help you remember to take it. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at the same time to make up for a missed dose. Do not stop taking the Erlotinib Tablet 150 mg without first consulting your doctor.

Safety Advice

• Alcohol: It is generally not recommended to drink alcohol while taking Zyceva 150 mg Strip. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Zyceva 150 mg Strip is safe for use in patients with mild to moderate kidney disease, no dose adjustment of Zyceva 150 mg Tablet is recommended. The use of Zyceva 150 mg Tablet is not recommended for severe kidney disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Breastfeeding: It is not recommended to breastfeed while taking Zyceva Tablet. Zyceva 150 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Zyceva 150 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Zyceva Tablet is safe for use in patients with mild to moderate liver disease, no dose adjustment of Zyceva 150 mg Tablet is recommended. The use of Erlotinib Tablet 150 mg is not recommended for severe liver disease patients. It is important to discuss all of your medical conditions and medications with your doctor to ensure that the treatment plan is safe and effective for you.
• Pregnancy: Use of Erlotinib Tablet 150 mg may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Zyceva 150 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Anti-cancer Drug Zyceva is unlikely to affect your ability to drive or operate machinery. If you experience any side effects while taking Zyceva 150 mg Tablet such as dizziness or drowsiness, it is important to avoid driving or operating heavy machinery until the side effects have resolved

bottom of page